Medical Data Vision Co., Ltd.
Stock Price Chart
2026/03/02 UpdatedPrice Trend
2026/03/02 UpdatedPrice & Trading Details
2026/03/02 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/03/01Earnings Calendar
Updated 2026/03/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2022/02/14 | ¥7.20 | ¥9.92 | +37.8% |
| 2020/02/09 | ¥2.90 | ¥6.06 | +109.0% |
Shareholder Composition
Updated 2026/03/01Major Holders
Updated 2026/03/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Vanguard International Stock Index-Total Intl Stock Indx
|
194.3K | 0.00% | |
|
DFA Japanese Small Company Series
|
149.3K | 0.00% | |
|
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
|
116.9K | 0.00% | |
|
DFA International Core Equity Portfolio
|
94.8K | -7.96% | |
|
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
|
63.4K | 0.00% | |
|
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
|
61.8K | 0.00% |
Dividend History
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2024 | ¥7 | 0.0% |
| 2023 | ¥7 | +8.3% |
| 2022 | ¥6 | +7.1% |
| 2021 | ¥6 | +86.7% |
| 2020 | ¥3 | - |
Financial Performance
2026/03/01 UpdatedNo financial data available
Latest IR Information
-
Notice Regarding Cancellation of Treasury Stock
Medical Data Vision Co., Ltd. announced plans to cancel 2,170,748 shares of treasury stock (approximately 5.42% of total outstanding shares) on April 27, 2026.
Read more -
Notice Regarding Stock Consolidation, Abolition of Unit Share System, and Partial Amendment of Articles of Incorporation
Following the acquisition of 52.34% of the Company's shares by the tender offeror, delisting is scheduled on April 24, 2026. The stock consolidation will merge 7,253,607 shares into 2 shares, reducing the number of issued shares by 37,856,768 to 10...
Read more -
Notice Regarding Recording of Extraordinary Loss (Impairment Loss on Investment Securities)
Recorded an extraordinary loss of 290 million yen due to a decline in the market value of investment securities in the Q4 consolidated accounting period of the fiscal year ending December 2025, reflected in the financial summary.
Read more -
Financial Summary for the Fiscal Year Ending December 2025 [Japan GAAP] (Consolidated)
Consolidated net sales for the fiscal year ending December 2025 amounted to 6,539,159 thousand yen (10.7% YoY increase), operating income was 349,464 thousand yen, and net income attributable to owners of parent was 280,242 thousand yen. Earnings guidance for the...
Read more -
Fiscal Year Ending December 2025 Financial Presentation Materials
For the fiscal year ending December 2025, net sales were 6,539 million yen, up 10.7% year-over-year (YoY). Operating income stood at 349 million yen, and net income attributable to owners of parent was 280 million yen.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥425
Rating Score: - (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Medical Data Vision Co., Ltd., together with its subsidiaries, develops, produces, maintains, and sells medical information integration systems in Japan, Europe, North America, Asia, and Oceania. The company offers data network services; data utilization services; MDV act, an analysis application that enables hospitals to preview hospital management indicators; and Karteco, a personal health record that enables users to independently manage their health and medical information. It also provides research, analysis, and consulting services for various medical data; business consulting services for medical institutions; operation and related services of various medical data; and planning, design, development, and operation of portal websites. The company serves hospitals, medical check centers, companies, and citizens. Medical Data Vision Co., Ltd. was incorporated in 2003 and is headquartered in Chiyoda, Japan. As of February 3, 2026, Medical Data Vision Co., Ltd. operates as a subsidiary of Nippon Life Insurance Company.
